Detalhe da pesquisa
1.
The 10th Biennial Hatter Cardiovascular Institute workshop: cellular protection-evaluating new directions in the setting of myocardial infarction, ischaemic stroke, and cardio-oncology.
Basic Res Cardiol
; 113(6): 43, 2018 10 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30310998
2.
The Caspase 1 Inhibitor VX-765 Protects the Isolated Rat Heart via the RISK Pathway.
Cardiovasc Drugs Ther
; 32(2): 165-168, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29582211
3.
Extracellular histones are a target in myocardial ischaemia-reperfusion injury.
Cardiovasc Res
; 118(4): 1115-1125, 2022 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33878183
4.
Mitochondrial cyclophilin-D as a potential therapeutic target for post-myocardial infarction heart failure.
J Cell Mol Med
; 15(11): 2443-51, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21143389
5.
SGLT2 Inhibitor, Canagliflozin, Attenuates Myocardial Infarction in the Diabetic and Nondiabetic Heart.
JACC Basic Transl Sci
; 4(1): 15-26, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30847415
6.
Plasma exosomes protect the myocardium from ischemia-reperfusion injury.
J Am Coll Cardiol
; 65(15): 1525-36, 2015 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-25881934
7.
SGLT2 inhibitors: reviving the sodium-hydrogen exchanger cardioprotection hypothesis?
Cardiovasc Res
; 115(10): 1454-1456, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31074777
8.
Preventing the Cancer Patient of Today From Becoming the Heart Failure Patient of Tomorrow.
JACC CardioOncol
; 1(2): 235-237, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34396186